A patient with advanced cirrhosis presents with hepatic encephalopathy, massive ascites, and large esophageal varices. Considering the recent diagnostic findings, which nursing intervention should be prioritized to prevent life-threatening complications?

D) Arrange for urgent endoscopic band ligation of esophageal varices.

A) Administer lactulose to reduce serum ammonia levels.

B) Prepare the patient for an immediate paracentesis to relieve ascites.

C) Initiate a beta-blocker therapy to decrease portal hypertension.

D) Arrange for urgent endoscopic band ligation of esophageal varices.

A patient with cirrhosis and portal hypertension presents with elevated ammonia levels, ascites, and esophageal varices. Based on these findings, which nursing intervention should be prioritized to prevent further complications?

A) Administer lactulose to reduce ammonia levels and monitor for signs of hepatic encephalopathy.

B) Initiate a sodium-restricted diet to manage ascites and prevent fluid overload.

C) Prepare the patient for endoscopic variceal ligation to prevent rebleeding from esophageal varices.

D) Administer fresh frozen plasma to correct the elevated INR and reduce the risk of bleeding.

A patient with advanced hepatic encephalopathy and respiratory distress is being evaluated for further management. Which nursing intervention should be prioritized to stabilize the patient's condition based on the current clinical findings?

B) Prepare for potential intubation and mechanical ventilation.

A) Initiate high-flow oxygen therapy to improve oxygen saturation.

B) Prepare for potential intubation and mechanical ventilation.

C) Administer intravenous fluids to correct hypotension.

D) Increase the frequency of lactulose administration to reduce ammonia levels.

A patient with advanced liver disease is exhibiting signs of worsening hepatic encephalopathy, hemodynamic instability, and respiratory distress. Considering the need to stabilize the patient, which of the following interventions should the nurse prioritize to address the patient's immediate needs?

A) Initiate mechanical ventilation to correct hypoxemia and support respiratory function.

B) Increase the frequency of lactulose administration to rapidly decrease ammonia levels.

C) Administer intravenous fluids to correct hypotension and support hemodynamic stability.

A patient with severe hepatic encephalopathy presents with critically elevated serum ammonia and a high INR of 2.3. The healthcare team plans to initiate a diuretic regimen with albumin to manage ascites and considers vitamin K supplementation. Which nursing intervention should take priority to ensure patient safety and improve outcomes?

A) Administering lactulose to reduce serum ammonia levels.

B) Preparing the patient for an immediate paracentesis to relieve ascites.

C) Monitoring neurological status closely to assess for worsening encephalopathy.

D) Educating the patient on dietary restrictions to manage liver dysfunction.

A patient with severe hepatic encephalopathy and acute hepatic decompensation presents with an elevated INR of 2.3 and worsening thrombocytopenia. The healthcare team is considering the initiation of a TIPS procedure. As the nurse, which intervention should be prioritized to minimize the risk of bleeding complications before the procedure?

C) Administer fresh frozen plasma to correct coagulopathy

A) Administer vitamin K to help reduce the INR

B) Increase diuretic dosage to manage ascites more effectively

C) Administer fresh frozen plasma to correct coagulopathy

D) Begin anticoagulation therapy to prevent thrombotic events

A 58-year-old patient with advanced cirrhosis presents with signs of worsening hepatic encephalopathy and hypotension after starting a diuretic regimen. Considering his deteriorating renal function and low serum sodium levels, which nursing intervention should be prioritized to stabilize his condition before considering a transjugular intrahepatic portosystemic shunt (TIPS) procedure?

B) Administer intravenous albumin to improve intravascular volume and renal perfusion.

A) Increase the diuretic dosage to manage ascites more effectively.

B) Administer intravenous albumin to improve intravascular volume and renal perfusion.

C) Restrict fluid intake to correct dilutional hyponatremia.

D) Initiate lactulose therapy to reduce ammonia levels and improve mental status.

Mr. Thompson, a 58-year-old patient with advanced cirrhosis, presents with signs of hepatic encephalopathy and potential hepatorenal syndrome. Given his current condition and the need for careful management, which of the following nursing actions is most appropriate to prioritize in this situation?

C) Initiate lactulose therapy to reduce ammonia levels and monitor neurological status closely.

A) Administer a higher dose of diuretics to manage ascites and improve renal function.

B) Prepare the patient for an immediate TIPS procedure to alleviate portal hypertension.

C) Initiate lactulose therapy to reduce ammonia levels and monitor neurological status closely.

D) Implement fluid restriction and monitor electrolytes to address dilutional hyponatremia.

A nurse is caring for Mr. Thompson, whose condition has deteriorated to Grade III hepatic encephalopathy with elevated ammonia levels and spontaneous bacterial peritonitis (SBP). Despite treatment interventions, his cardiovascular status remains unstable with persistent hypotension. Which nursing intervention is MOST critical to prioritize in this scenario?

C) Monitor for signs of hepatorenal syndrome and adjust vasopressor therapy.

A) Administer lactulose to reduce ammonia levels.

B) Initiate broad-spectrum antibiotics for SBP.

C) Monitor for signs of hepatorenal syndrome and adjust vasopressor therapy.

D) Prepare for possible intubation due to risk of respiratory failure.

A nurse is reviewing the management plan for Mr. Thompson, who has Grade III hepatic encephalopathy, spontaneous bacterial peritonitis (SBP), and signs of hepatorenal syndrome. Which of the following interventions should the nurse prioritize to address Mr. Thompson's multifaceted condition?

B) Administer broad-spectrum antibiotics immediately to treat spontaneous bacterial peritonitis while awaiting culture results.

A) Intensify lactulose therapy to reduce ammonia levels and monitor for bowel movement frequency.

B) Administer broad-spectrum antibiotics immediately to treat spontaneous bacterial peritonitis while awaiting culture results.

C) Initiate midodrine and octreotide to improve renal perfusion and manage hepatorenal syndrome.

D) Adjust vasopressor support to maintain perfusion, focusing on cardiovascular stabilization.

Cirrhosis - Nursing Case Study

Pathophysiology

• Primary mechanism: Chronic liver injury from factors like alcohol, viral hepatitis, or non-alcoholic steatohepatitis leads to persistent inflammation, triggering hepatocyte necrosis and fibrosis. This fibrosis disrupts normal liver architecture by forming regenerative nodules, compromising liver function.

• Secondary mechanism: Fibrosis and nodular regeneration increase intrahepatic vascular resistance, resulting in portal hypertension. This causes blood to bypass the liver and form varices, ascites, and splenomegaly, further impairing liver function and nutrient processing.

• Key complication: Portal hypertension and impaired liver detoxification can cause hepatic encephalopathy due to the accumulation of neurotoxins like ammonia, leading to altered mental status and potential coma if untreated.

Patient Profile

Demographics:

58-year-old male, retired construction worker

History:

• Key past medical history: Chronic hepatitis C infection, alcohol abuse (30-year history), type 2 diabetes mellitus

• Current medications: Lactulose, spironolactone, furosemide, propranolol, metformin

• Allergies: Penicillin (rash)

Current Presentation:

• Chief complaint: Abdominal distension and confusion

• Key symptoms: Severe ascites, jaundice, hepatic encephalopathy, esophageal variceal bleeding, peripheral edema

• Vital signs: Blood pressure 90/60 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 38.3°C, oxygen saturation 88% on room air

Section 1

New Diagnostic Results:

Following the initial assessment, a series of diagnostic tests were conducted to gain a clearer understanding of the patient’s condition and to guide further management. Laboratory results revealed significant derangements: an elevated serum ammonia level of 115 µmol/L (normal range: 15-45 µmol/L), reflecting the extent of hepatic encephalopathy. Liver function tests showed a markedly elevated total bilirubin of 7.5 mg/dL (normal range: 0.1-1.2 mg/dL), and serum albumin was low at 2.3 g/dL (normal range: 3.5-5.0 g/dL), indicating impaired synthetic function of the liver. Coagulation profile was also disturbed with an international normalized ratio (INR) of 2.2, highlighting the risk for further bleeding complications.

Imaging studies, including an abdominal ultrasound, confirmed the presence of massive ascites and revealed splenomegaly with signs of portal hypertension. Doppler ultrasound of the hepatic vasculature indicated reduced flow in the portal vein, consistent with significant portal hypertension. Additionally, endoscopy conducted due to the history of esophageal variceal bleeding showed large esophageal varices, some of which had red wale markings, indicating a high risk for rebleeding.

These diagnostic findings underscore the critical nature of the patient’s cirrhotic state and the urgent need for targeted interventions to manage the complications of portal hypertension, prevent further episodes of variceal bleeding, and address the hepatic encephalopathy. The healthcare team must now strategize to stabilize the patient’s hemodynamics, control the ascites, and reduce ammonia levels while preparing for potential emergent procedures such as variceal band ligation or transjugular intrahepatic portosystemic shunt (TIPS) if the patient's condition does not improve with medical management alone.

Section 2

Change in Patient Status:

Despite initial interventions, the patient's clinical status deteriorated rapidly over the next 48 hours, underscoring the severity of their condition. The patient developed increasing confusion and disorientation, consistent with worsening hepatic encephalopathy. Neurological assessment revealed asterixis, and the patient's Glasgow Coma Scale (GCS) score dropped from 14 to 10, indicating a decline in mental status. Vital signs showed hypotension with a blood pressure of 88/54 mmHg and tachycardia at 112 beats per minute, suggesting hemodynamic instability likely exacerbated by the massive ascites and third spacing of fluids.

Concurrent with these neurological changes, the patient's respiratory status began to decline as well. They exhibited signs of respiratory distress, including tachypnea with a respiratory rate of 28 breaths per minute and decreased oxygen saturation of 89% on room air. The presence of ascites was likely contributing to diaphragmatic elevation and reduced lung volumes. Arterial blood gas analysis showed a respiratory alkalosis with a pH of 7.48, PaCO2 of 30 mmHg, and PaO2 of 65 mmHg, indicating the onset of hypoxemia and compensatory hyperventilation.

Given these developments, the healthcare team needed to reassess and intensify the management approach. The immediate priorities shifted towards stabilizing the patient's hemodynamic and respiratory status while aggressively addressing the hepatic encephalopathy. Lactulose administration was adjusted to increase frequency, aiming to reduce serum ammonia levels promptly. Additionally, discussions regarding the potential need for mechanical ventilation support and the urgent consideration of a transjugular intrahepatic portosystemic shunt (TIPS) procedure became imperative to mitigate the effects of portal hypertension and prevent further complications. The evolving complexity of the patient's condition required advanced clinical judgment to prioritize interventions and anticipate further complications.

Section 3

New Diagnostic Results:

In response to the patient's rapidly deteriorating condition, the healthcare team ordered an urgent panel of diagnostic tests to better understand the underlying causes of the patient's hemodynamic and respiratory instability. Laboratory results revealed a critically elevated serum ammonia level of 185 µmol/L, confirming the severe hepatic encephalopathy and necessitating immediate intervention. Liver function tests showed a marked increase in bilirubin at 5.8 mg/dL, with alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels significantly elevated, at 75 U/L and 92 U/L respectively, indicating acute hepatic decompensation.

Additionally, a complete blood count highlighted worsening thrombocytopenia with a platelet count of 58,000/mm³, raising concerns for potential bleeding complications. Coagulation profile results were alarming, with an international normalized ratio (INR) of 2.3, suggesting a high risk for spontaneous hemorrhage. Imaging studies, including an abdominal ultrasound, confirmed the presence of massive ascites and revealed new-onset splenomegaly, indicative of worsening portal hypertension.

These findings prompted the healthcare team to initiate a more aggressive therapeutic approach. It was decided to commence a diuretic regimen with intravenous albumin to manage the ascites, along with careful monitoring of renal function due to the risk of hepatorenal syndrome. Given the elevated INR and the potential for bleeding, the team also initiated vitamin K supplementation and debated the judicious use of fresh frozen plasma. The diagnostic results not only underscored the urgency of the situation but also guided the team in refining their treatment strategy to stabilize the patient and prevent further complications. These developments set the stage for the next phase of critical decision-making, particularly regarding the feasibility and timing of a TIPS procedure amidst the patient's fragile clinical status.

Section 4

The patient, Mr. Thompson, age 58, diagnosed with advanced cirrhosis, began to exhibit further complications despite the initiation of an aggressive management plan. Within 24 hours of starting the diuretic regimen and vitamin K supplementation, his condition necessitated a reevaluation. The nursing team observed a marked change in his mental status; he became increasingly lethargic and disoriented, raising concerns of worsening hepatic encephalopathy. His vital signs also revealed significant hypotension, with blood pressure dropping to 85/55 mmHg, alongside tachycardia at 115 beats per minute. These changes suggested he might be developing a hepatorenal syndrome, a dire complication of cirrhosis.

New laboratory results painted a grim picture. Serum creatinine levels rose sharply to 2.3 mg/dL from a baseline of 1.0 mg/dL, confirming deteriorating renal function. Concurrently, the patient's serum sodium plummeted to 125 mEq/L, indicating possible dilutional hyponatremia from the massive fluid shifts associated with his ascites. The decision to use diuretics was revisited, considering the potential exacerbation of renal impairment. Moreover, despite intravenous albumin administration, his albumin levels remained critically low at 2.0 g/dL, reinforcing the need for nutritional support and potentially more aggressive albumin replacement.

The healthcare team faced a critical decision point, balancing the risks and benefits of a transjugular intrahepatic portosystemic shunt (TIPS) procedure. While TIPS could alleviate portal hypertension and reduce ascites, the concern for precipitating further hepatic encephalopathy was significant given his current neurological status. The team engaged in a multidisciplinary discussion, weighing the feasibility of proceeding with TIPS against the backdrop of Mr. Thompson's fragile clinical state and considering alternative strategies to optimize his hemodynamic stability and renal function before any invasive intervention.

Section 5

As the clinical team continued to assess Mr. Thompson, further changes in his condition emerged, necessitating immediate attention and a reevaluation of the current management plan. Despite initial interventions, Mr. Thompson's mental status deteriorated further, progressing to a state of confusion and agitation, consistent with Grade III hepatic encephalopathy. His ammonia levels were found to be critically elevated at 120 µmol/L, confirming the exacerbation of hepatic encephalopathy. In response, lactulose dosing was intensified, and rifaximin was introduced to help reduce ammonia production in the gut.

Concurrently, additional diagnostic imaging was performed to assess the severity of ascites and potential complications. An abdominal ultrasound revealed worsening ascites with evidence of spontaneous bacterial peritonitis (SBP), as indicated by a cloudy peritoneal fluid aspirate and an elevated white cell count of 350 cells/mm³, predominantly neutrophils. Broad-spectrum antibiotics were promptly initiated, targeting common pathogens associated with SBP, while cultures were pending to tailor therapy.

Mr. Thompson's cardiovascular status remained precarious, with persistent hypotension despite cautious fluid resuscitation and vasopressor support to maintain perfusion. His heart rate continued to be elevated at 120 beats per minute, and he exhibited signs of peripheral vasoconstriction with cool extremities. The clinical team explored the use of midodrine and octreotide to manage hepatorenal syndrome, aiming to improve renal perfusion without exacerbating his already fragile hemodynamic balance. These measures were carefully monitored, recognizing the delicate interplay between liver function, renal status, and the risk of further decompensation. This evolving scenario underscored the complexity of Mr. Thompson's case, requiring vigilant monitoring and dynamic adjustments to his treatment plan.